Advertisement

Compounding News

June 23, 2017
June 23, 2017
In June 2017, APhA provided comments to FDA at three Listening Sessions on compounding. Pharmacy organizations. APhA reiterated our support for...
Comments addressed office use, radiopharmaceuticals, hospital compounding
MORE
May 05, 2017
May 05, 2017
Today, President Donald J. Trump signed into law H.R. 244, which provides fiscal year 2017 full-year appropriations through September 30, 2017, for...
President signs legislation to avoid government shutdown
MORE
January 17, 2017
January 17, 2017
At the end of 2016, FDA issued final guidance that will require pharmacists to obtain a valid “patient-specific prescription” for each drug...
APhA opposes final guidance in joint comments
MORE
November 07, 2016
November 07, 2016
Compounding is an important part of pharmacy practice as it permits patients with unique medical needs to have access to vital medications.  APhA...
Association submits recommendations on insanitary conditions at compounding facilities and on compounded drug products that are essentially copies of a commercially available drug product
MORE
May 03, 2016
May 03, 2016
Rep. Buddy Carter (R-GA), BSPharm, on April 28 delivered an impassioned speech on the House floor in protest of recent FDA draft guidance on...
Agency’s draft guidance would prohibit most office-use compounding
MORE
November 01, 2015
October 28, 2015
USP is urging pharmacist stakeholders to review proposed revisions to one of its national standards for compounded preparations.
 The chapter,...
Revisions to USP <797> under way
MORE
September 29, 2015
September 29, 2015
The U.S. Pharmacopeial Convention (USP) is urging pharmacist stakeholders to review proposed revisions to General Chapter <797> Pharmaceutical...
Revisions to USP <797> under way
MORE
September 01, 2015
August 28, 2015
The pharmacy compounding industry was changed forever after the 2012 fungal meningitis outbreak attributed to the New England Compounding Center. In...
Determining the benefits of registering as an outsourcing facility under the 2013 compounding law
MORE
April 01, 2015
March 31, 2015
FDA’s newly configured, 14-member Pharmacy Compounding Advisory Committee (PCAC) convened on February 23–24 at FDA headquarters in suburban...
PCAC added 25 drugs to agency’s do-not-compound list; deemed two bulk drug substances unfit for agency’s bulk list
MORE
February 19, 2015
February 19, 2015
FDA continues to issue guidance on how to enforce the Drug Quality and Security Act after the compounding law was enacted in late 2013. The agency...
Guidance pertains to 2013 compounding law’s 503A and 503B, along with a draft memorandum of understanding
MORE

Pages